email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
3001 - 3015
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Akonni and Righton Form Two-Way US-China Diagnostics Deal
$5.00
Available
Cellular Biomedicine Will Focus on China, Closing California Operations
$5.00
Available
Shenzhen Breaks Ground on James Watson-led Life Science Research Center
$5.00
Available
Infervision Closes $47 Million B+ Round for AI-aided CT Scan Analysis
$5.00
Available
HitGen to Discover Leads for BASF Crop Protection Products
$5.00
Available
China Plans to Move the CFDA into a New Agency
$5.00
Available
United Biopharma of Taiwan to Build $40 Million mAb Manufacturing Facility in China
$5.00
Available
Timwell Forms $20 Million JV with ReWalk for China Sales of Exoskeleton
$5.00
Available
Alibaba Re-Starts $1.4 Billion Bid to Acquire iKang Healthcare
$5.00
Available
Chi-Med Expects Approval of First Novel Cancer Drug in 2018
$5.00
Available
XW Labs Starts Phase I Trial of Novel Narcolepsy Candidate
$5.00
Available
Hua Medicine in Hong Kong IPO Queue; Plans to Raise $400 Million
$5.00
Available
Adagene to Collaborate with WuXi Biologics for Antibody Manufacturing
$5.00
Available
JW, a Juno-WuXi AppTec China JV, Raises $90 Million for CAR-T Drugs
$5.00
Available
US FDA Approves Drug-Resistant HIV Treatment from Taiwan's TaiMed
$5.00
Available